Back
Tango Therapeutics 10K Form
Sell
27
TNGX
Tango Therapeutics
Last Price:
4.10
Seasonality Move:
3.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TNGX News And Ratings
See the #1 stock for the next 7 days that we like better than TNGX
TNGX Financial Statistics
Sales & Book Value
| Annual Sales: | $36.53M |
|---|---|
| Cash Flow: | $-33.51M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.13 |
| Price / Book: | 1.57 |
Profitability
| EPS (TTM): | -1.16000 |
|---|---|
| Net Income (TTM): | $-123.4M |
| Gross Margin: | -- |
| Return on Equity: | -48.54% |
| Return on Assets: | -31.31% |
Tango Therapeutics Earnings Forecast
Key Tango Therapeutics Financial Ratios
- The Research & Development expenses have been 315.38% of Revenue.
- The Net Earning history of TNGX is -278.54% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 1 years.
Tango Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TNGX |
| Website: | tangotx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8 |
| Quick Ratio: | 7.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TNGX Technical Analysis vs Fundamental Analysis
Sell
27
Tango Therapeutics (TNGX)
is a Sell
Is Tango Therapeutics a Buy or a Sell?
-
Tango Therapeutics stock is rated a Sell
The current Tango Therapeutics [TNGX] share price is $3.56. The Score for TNGX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.